Finnrick, an independent testing programme, publishes 10 assays for Huaian Dinglin Trading: 6 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 4 did not. Most recent assay 12 Jun 2026.
Huaian Dinglin Trading operates from China, listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/huaian-dinglin-trading.
Huaian Dinglin Trading is listed as active.
| Product | Assays | Result |
|---|---|---|
| Retatrutide | 6 | 5 passed, 1 failed |
| Tesamorelin | 4 | 1 passed, 3 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Vendor type | Research-use supplier |
These details were read from Huaian Dinglin Trading's own website on 2026-08-17. Pages consulted:
Huaian Dinglin Trading is listed as active and we hold 10 Finnrick assays (6 passing, 4 failing its purity threshold). That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 10 assays for Huaian Dinglin Trading: 6 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 4 did not. Most recent assay 12 Jun 2026.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Huaian Hanyou Peptide Review, Huatai Peptide Review, Huayi Biotechnology Peptides Review.